Moving the Needle Forward With Locoregional Treatment in Unresectable Cholangiocarcinoma—The Jury Is Still Out
Author:
Affiliation:
1. Division of Hematology and Oncology, Department of Medicine, University of Arizona Cancer Center, Tucson
Publisher
American Medical Association (AMA)
Subject
Oncology,Cancer Research
Link
https://jamanetwork.com/journals/jamaoncology/articlepdf/2753553/jamaoncology_scott_2019_ed_190018.pdf
Reference15 articles.
1. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.;Nakeeb;Ann Surg,1996
2. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.;DeOliveira;Ann Surg,2007
3. Forty-year trends in cholangiocarcinoma incidence in the US: intrahepatic disease on the rise.;Saha;Oncologist,2016
4. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.;Jarnagin;Ann Surg,2001
5. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.;Valle;N Engl J Med,2010
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Preoperative neutrophil-to-lymphocyte ratio is prognostic for early recurrence after curative intrahepatic cholangiocarcinoma resection;Annals of Hepato-Biliary-Pancreatic Surgery;2023-02-20
2. Optimizing Circulating Tumour DNA Use in the Perioperative Setting for Intrahepatic Cholangiocarcinoma: Diagnosis, Screening, Minimal Residual Disease Detection and Treatment Response Monitoring;Annals of Surgical Oncology;2023-02-20
3. Is it safe to administer neoadjuvant chemotherapy to patients undergoing hepatectomy for intrahepatic cholangiocarcinoma? ACS-NSQIP propensity-matched analysis;HPB;2022-09
4. Systematic Review and Meta-Analysis of Prognostic Factors for Early Recurrence in Intrahepatic Cholangiocarcinoma After Curative-Intent Resection;Annals of Surgical Oncology;2022-02-18
5. Current challenges to underpinning the genetic basis for cholangiocarcinoma;Expert Review of Gastroenterology & Hepatology;2021-04-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3